Guidance document : cancellation of a drug identification number (DIN) and notification of discontinuation of sales.: H13-9/10-2018E-PDF

"A Drug Identification Number (DIN) serves as an identifier of a drug and its associated characteristics. The assignment of a DIN indicates that a drug has undergone a successful Health Canada review process and is currently authorized for sale in Canada. The purpose of this guidance document is to provide assistance in interpreting sections C.01.014.6 and C.01.014.7 of the Regulations for the cancellation of a DIN and the notification to Health Canada of the discontinuation of the sale of a drug"--P. 7.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.854395&sl=0

Publication information
Department/Agency Canada. Health Canada.
Title Guidance document : cancellation of a drug identification number (DIN) and notification of discontinuation of sales.
Variant title Cancellation of a drug identification number (DIN) and notification of discontinuation of sales
Cancellation of a DIN & notification of discontinuation of sales
Publication type Monograph
Language [English]
Other language editions [French]
Format Electronic
Electronic document
Note(s) Issued also in French under title: Ligne directrice : annulation d’une identification numérique d’une drogue (DIN) et avis de cessation de la vente d’une drogue.
Cover title.
"Date adopted: 2017/03/14. Revision date: 2018/06/13. Effective date: 2018/06/13."
"Publication date: June 2018."
Issued also in HTML format.
Includes bibliographical references.
Publishing information Ottawa : Health Canada, 2018.
Description 18 p.
ISBN 9780660260105
Catalogue number
  • H13-9/10-2018E-PDF
Departmental catalogue number 170513
Subject terms Drugs
Product elimination
Handbooks
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.
Date modified: